Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Vomiting 27Nausea 20Neoplasms 8Breast Neoplasms 6Lymphoma 3Stomach Neoplasms 2Rectal Neoplasms 2Lymphoma, Non-Hodgkin 2Lung Neoplasms 2Leukemia 2Hematologic Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Weight Loss 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Sarcoma 1Pancreatic Neoplasms 1Pain 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Melanoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Inflammatory Breast Neoplasms 1Hematologic Diseases 1Glioma 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1

Interventions

Exercise 10Diet 6Caloric Restriction 5Metformin 4Octreotide 3Nutrition Assessment 3Cognitive Behavioral Therapy 3anamorelin 2Standard of Care 2Olanzapine 2Mirtazapine 2Melatonin 2Liraglutide 2Eicosapentaenoic Acid 2Diet, Carbohydrate-Restricted 2Diet Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1lime 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1Urine Specimen Collection 1Tirzepatide 1TOPS 1Surveys and Questionnaires 1Sugars 1Sampling Studies 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Weight Loss × Palonosetron × Clear all
NCT00412425 2012-05-04

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

M.D. Anderson Cancer Center

Phase 1/2 Completed
30 enrolled 4 charts
Dermatologic

Anorexia, Melanoma, Nausea, Vomiting, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡